Brief: Grace Therapeutics Announces Alignment With The FDA Supporting The Submission For Gtx-104
09/04/2025 13:13
April 9 (Reuters) - Grace Therapeutics, Inc GRCE.O: GRACE THERAPEUTICS ANNOUNCES ALIGNMENT WITH THE FDA SUPPORTING THE PLANNED NDA SUBMISSION FOR GTX-104 GRACE THERAPEUTICS, INC: ANTICIPATES FILING ITS NDA FOR GTX-104 IN Q2 OF 2025 Source text: ID:nGNX5nQHtZ Further company coverage: GRCE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grace Therapeutics
See all newsBrief: Grace Therapeutics - Selling Stockholders May Resell Up To 4,761,904 Shares Of Common Stock - SEC Filing
Grace Therapeutics Q1 net loss widens on impairment charges
Grace Therapeutics falls after FDA declines to approve stroke drug
NASDAQ RESUMED AT 01:57 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:52 PM